{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:38:46Z","timestamp":1792726726300,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tjpad.2026.100519","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:16:03Z","timestamp":1772230563000},"page":"100519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Memory Consolidation and ARIA in Individuals Receiving Anti-amyloid Monoclonal Antibodies"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-362X","authenticated-orcid":false,"given":"Marc W.","family":"Haut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Vieira Ligo","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"Worhunsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-7435","authenticated-orcid":false,"given":"Rashi I.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cierra M.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3501-8628","authenticated-orcid":false,"given":"Holly E.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pockl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiisah","family":"Rajabalee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Marano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Francois","family":"D\u2019Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Rezai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tjpad.2026.100519_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100519_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100519_bib0003","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tjpad.2026.100519_bib0004","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2026.100519_bib0005","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100519_bib0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41582-024-01053-8","article-title":"Amyloid-related imaging abnormalities: manifestations, metrics and mechanisms","volume":"21","author":"Greenberg","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2026.100519_bib0007","doi-asserted-by":"crossref","first-page":"221","DOI":"10.14283\/jpad.2022.34","article-title":"Aducanumab: appropriate use recommendations update","volume":"9","author":"Cummings","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100519_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: appropriate use recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.tjpad.2026.100519_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100150","article-title":"Donanemab: appropriate use recommendations","volume":"12","author":"Rabinovici","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100519_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.57.6.839","article-title":"The course of cognitive impairment in preclinical Alzheimer disease: three-and 6-year follow-up of a population-based sample","volume":"57","author":"Small","year":"2000","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2026.100519_bib0011","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/13825585.2022.2144618","article-title":"Frontal and temporal lobe correlates of verbal learning and memory in aMCI and suspected Alzheimer\u2019s disease dementia","volume":"30","author":"Keith","year":"2023","journal-title":"Aging Neuropsychol Cogn"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100519_bib0012","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100519_bib0013","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2026.100519_bib0014","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/alz.13466","article-title":"The sporadic early-onset Alzheimer's disease signature of atrophy: preliminary findings from the longitudinal early-onset Alzheimer's disease study (LEADS) cohort","volume":"19","author":"Touroutoglou","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2026.100519_bib0015","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.tjpad.2026.100519_bib0016","article-title":"California verbal learning test","author":"Delis","year":"2000"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100519_bib0017","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/13872877241291223","article-title":"Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-\u03b2 positive and negative mild cognitive impairment","volume":"102","author":"Keith","year":"2024","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.tjpad.2026.100519_bib0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.tjpad.2026.100519_bib0019","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","article-title":"Measurement of functional activities in older adults in the community","volume":"37","author":"Pfeffer","year":"1982","journal-title":"J Gerontol"},{"key":"10.1016\/j.tjpad.2026.100519_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.tjpad.2026.100519_bib0021","series-title":"WRAT 4: wide range achievement test","author":"Wilkinson","year":"2006"},{"key":"10.1016\/j.tjpad.2026.100519_bib0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuroimage.2019.03.041","article-title":"3D whole brain segmentation using spatially localized atlas network tiles","volume":"194","author":"Huo","year":"2019","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100519_bib0023","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","article-title":"An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis","volume":"59","author":"Schmidt","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.tjpad.2026.100519_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70062","article-title":"Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimer's & Dementia"},{"issue":"3","key":"10.1016\/j.tjpad.2026.100519_bib0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1037\/0894-4105.8.3.374","article-title":"Preclinical cognitive markers of dementia of the Alzheimer type","volume":"8","author":"Bondi","year":"1994","journal-title":"Neuropsychol"},{"key":"10.1016\/j.tjpad.2026.100519_bib0026","article-title":"Semantic intrusion errors differentiate between amnestic MCI who are plasma p-tau217+ from p-tau217-after adjusting for initial learning strength","volume":"16","author":"Curiel","year":"2025","journal-title":"Front Neurol"},{"issue":"10","key":"10.1016\/j.tjpad.2026.100519_bib0027","first-page":"e976","article-title":"Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment","volume":"91","author":"Loewenstein","year":"2018","journal-title":"Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100519_bib0028","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/ADR-230049","article-title":"More similar than different: memory, executive functions, cortical thickness, and glucose metabolism in biomarker-positive Alzheimer\u2019s disease and behavioral variant frontotemporal dementia","volume":"8","author":"Keith","year":"2024","journal-title":"Alzheimers Dis Rep"},{"issue":"1","key":"10.1016\/j.tjpad.2026.100519_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamaneurol.2024.3937","article-title":"Amyloid-related imaging abnormalities (ARIA) in clinical trials of gantenerumab in early Alzheimer disease","volume":"82","author":"Salloway","year":"2025","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2026.100519_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100209","article-title":"Cerebrovascular disease in Alzheimer's disease: brain structure as a critical mediator of cognitive decline","volume":"12","author":"Tang","year":"2025","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726000439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:04:25Z","timestamp":1792724665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726000439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2274580726000439"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100519","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Memory Consolidation and ARIA in Individuals Receiving Anti-amyloid Monoclonal Antibodies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100519"}}